Federated, Accessible, Inclusive, and Responsive Virtual Biorepository: Delphi Consensus Study
4 affiliations
- 1Dartmouth Health, Lebanon, NH, United States
- 2Center for Global Health, Colorado School of Public Health, University of Colorado, 13001 East 17th Place, Mail Stop B119, Aurora, CO, 80045, United States, 1 303 724 4869
- 3Oakland University, Rochester, MI, United States
- 4Infectious and Tropical Medicine, Heidelberg Institute for Global Health, Heidlberg University, Heidelberg, Germany
Abstract
Background: The reemergence of the Zika virus, the novel coronavirus, and new influenza strains highlighted the urgent need for an organized forum to access specimens to advance research, diagnostics, and vaccine development. During the COVID-19 pandemic, gaps in supply chains, communication, and standards between local (federated) and centralized systems cost time and lives. The FAIR-VBS (Federated, Accessible, Inclusive, and Responsive Virtual Biorepository) was proposed to connect communities with samples, address specimen-sharing challenges, and promote inclusion and equity.
Objective: This study aims to enable equitable contribution, sharing, and access to specimens while addressing the complexities involved. The objective is to build stakeholder consensus on prioritized actions, tools, and responsibilities to establish a functional and practical FAIR-VBS.
Methods: A Delphi process was conducted online to gather stakeholder input and develop a prioritized action plan for the FAIR-VBS. Respondents were recruited using snowball sampling, and questions were informed by participatory workshops, feedback, outreach efforts, and discussions to identify gaps and best practices. The Delphi process consisted of 2 rounds: an initial ranking informed by stakeholder input and a second round to refine priorities based on the panel feedback. Items were evaluated using a standardized 5-point Likert scale and retained if prioritized by at least 70% of respondents rating an item 4 or higher and no more than 15% rating an item below 2, with descriptive statistics applied. Advisory board discussions supplemented the virtual process to capture nuances, while qualitative data were analyzed using participatory action research methods.
Results: The Delphi process evaluated 34 cumulative items across 2 rounds to identify critical gaps and priorities in biorepository systems. In the first round, 22 out of 30 initial items successfully reached consensus. Panelists organically proposed 4 additional items during the first round; upon evaluation in the second round, 2 of these newly proposed items reached consensus, addressing benefit-sharing challenges (11/15, 73%) and the prioritization of whole blood, plasma, and serum samples (40/42, 95%). Culturally, peripheral blood mononuclear cells were supported as a secondary priority (13/18, 72%). In total, 24 items achieved consensus across both rounds, while 10 items overall did not. Respondents overwhelmingly supported the hybrid FAIR-VBS, which combines federated and centralized systems, offering local convenience with virtual oversight (34/41, 83%). Cost recovery for services was supported by all respondents (43/43, 100%), with a preference for a sliding fee scale to subsidize capacity building in low- and middle-income countries (40/42, 95%).
Conclusions: Respondents strongly supported the FAIR-VBS to enable equitable access to specimens, services, and benefits. They emphasized the need for clarity on benefit-sharing, regulatory, and ethical frameworks to ensure effective implementation and global inclusivity. A fair and equivalent system to enhance participation and operational continuity is being discussed.
Related
- Developing the World‐Wide FINGERS biorepository for dementia risk reduction trials
- Socioeconomic position and cardiometabolic risk factors in children and adolescents with obesity: findings from the Bern Obesity in Childhood and Adolescence Biorepository (BOCAB)
- Clinically Accessible Phenotypes Refine Cardiovascular Risk Stratification Beyond Contemporary Clinical Equations
- SPLASH: a benchtop platform for accessible, ultrasensitive quantification of plasma biomarkers in Alzheimer’s disease
- A New Accessible Six-Strand Flexor Tendon Repair Technique: A Four-Group Comparative Study on a Porcine Model
BibTeX
@article{price2026federated,
title = {{Federated, Accessible, Inclusive, and Responsive Virtual Biorepository: Delphi Consensus Study}},
author = {Amy Price and Layla Abdulbaki and Julia Poje and Judith Giri and Zoe Steinberg and Thomas Jaenisch and May Chu},
journal = {JMIR Public Health and Surveillance},
year = {2026},
month = nov,
doi = {10.2196/87458},
url = {https://doi.org/10.2196/87458},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Federated, Accessible, Inclusive, and Responsive Virtual Biorepository: Delphi Consensus Study
AU - Amy Price
AU - Layla Abdulbaki
AU - Julia Poje
AU - Judith Giri
AU - Zoe Steinberg
AU - Thomas Jaenisch
AU - May Chu
PY - 2026
DA - 2026/11/12
JO - JMIR Public Health and Surveillance
DO - 10.2196/87458
UR - https://doi.org/10.2196/87458
AB - Background: The reemergence of the Zika virus, the novel coronavirus, and new influenza strains highlighted the urgent need for an organized forum to access specimens to advance research, diagnostics, and vaccine development. During the COVID-19 pandemic, gaps in supply chains, communication, and standards between local (federated) and centralized systems cost time and lives. The FAIR-VBS (Federated, Accessible, Inclusive, and Responsive Virtual Biorepository) was proposed to connect communities with samples, address specimen-sharing challenges, and promote inclusion and equity. Objective: This study aims to enable equitable contribution, sharing, and access to specimens while addressing the complexities involved. The objective is to build stakeholder consensus on prioritized actions, tools, and responsibilities to establish a functional and practical FAIR-VBS. Methods: A Delphi process was conducted online to gather stakeholder input and develop a prioritized action plan for the FAIR-VBS. Respondents were recruited using snowball sampling, and questions were informed by participatory workshops, feedback, outreach efforts, and discussions to identify gaps and best practices. The Delphi process consisted of 2 rounds: an initial ranking informed by stakeholder input and a second round to refine priorities based on the panel feedback. Items were evaluated using a standardized 5-point Likert scale and retained if prioritized by at least 70% of respondents rating an item 4 or higher and no more than 15% rating an item below 2, with descriptive statistics applied. Advisory board discussions supplemented the virtual process to capture nuances, while qualitative data were analyzed using participatory action research methods. Results: The Delphi process evaluated 34 cumulative items across 2 rounds to identify critical gaps and priorities in biorepository systems. In the first round, 22 out of 30 initial items successfully reached consensus. Panelists organically proposed 4 additional items during the first round; upon evaluation in the second round, 2 of these newly proposed items reached consensus, addressing benefit-sharing challenges (11/15, 73%) and the prioritization of whole blood, plasma, and serum samples (40/42, 95%). Culturally, peripheral blood mononuclear cells were supported as a secondary priority (13/18, 72%). In total, 24 items achieved consensus across both rounds, while 10 items overall did not. Respondents overwhelmingly supported the hybrid FAIR-VBS, which combines federated and centralized systems, offering local convenience with virtual oversight (34/41, 83%). Cost recovery for services was supported by all respondents (43/43, 100%), with a preference for a sliding fee scale to subsidize capacity building in low- and middle-income countries (40/42, 95%). Conclusions: Respondents strongly supported the FAIR-VBS to enable equitable access to specimens, services, and benefits. They emphasized the need for clarity on benefit-sharing, regulatory, and ethical frameworks to ensure effective implementation and global inclusivity. A fair and equivalent system to enhance participation and operational continuity is being discussed.
SN - 2369-2960
ER -